Mader G, Purser M, Mladsi D, Sanon M, Oberdhan D, Watnick T, Seliger S. Benefit of tolvaptan on time to End-stage Renal Disease (ESRD) for patients with rapidly progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD): a disease progression model. Poster presented at the 2020 National Kidney Foundation Spring Clinical Meeting; March 2020. New Orleans, LA. [abstract] Am J Kidney Dis. 2020 Apr; 75(4):603.
Parikh RC, Lairson DR, Cormier JN, Du XL. Cost-utility analysis of various chemotherapy regimens among elderly ovarian cancer patients: a longitudinal cohort study. Poster presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Conference; August 2013. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):172. doi: 10.1002/pds.3512